Please login to the form below

I have forgotten my password

Zoetis

This page shows the latest Zoetis news and features for those working in and with pharma, biotech and healthcare.

Pfizer mulling product sale to streamline ops; sources

unit Zoetis to deal with accretion and dilution.

Latest news

Sanofi and Boehringer Ingelheim complete €21.8bn asset swap

Boehringer's animal health unit is now the second-largest in the business, only surpassed by Pfizer spin-out Zoetis.
Pfizer decides against long-discussed break-up

The company has been deliberating a split since it span out its animal health division via an initial public offering (IPO) into stand-alone company Zoetis, and in particular had been
Sanofi and Boehringer agree asset swap deal

The veterinary sector saw Pfizer spin out its Zoetis unit - the biggest player in the market - in 2011, while Elanco bought Novartis' unit last year to claim the second spot ahead
UK government fines GSK over 'pay-for-delay' deals

other subsidiaries including Xellia Pharma and Zoetis Products LLC.
Sanofi and Boehringer in $20bn asset swap negotiations

Boehringer, meanwhile, would become the second-largest animal health company after Pfizer spin-out Zoetis if the deal goes through, with pro forma sales of 3.8bn in 2015 putting it

More from news
Approximately 2 fully matching, plus 24 partially matching documents found.

Latest Intelligence

Pharma deals during November 2014

form of Zoetis who this month acquired Abbott's animal health business for $255m. ... Bill Ackman, a Valeant investor, now owns 8.5% of Zoetis, which may pave the way for a potential deal.
Pharma deals during April 2014

spot in terms of sales, second only to Zoetis.
Pharma deals during January 2014

Several major pharma firms are deciding where to focus their business interests with Pfizer spinning out Zoetis for its animal health interests and Abbott doing the same for its pharma business,
Pharma deals during December 2012

2012. The next major event in the animal health deal calendar will probably be the IPO of Pfizer's animal health business (named in the IPO documents as Zoetis) which had

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Account Director – UK Office: Excellent salary and benefits

Account Director, Healthcare Communications: Salary TBC

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Empowered patients: shaking the foundations of healthcare: Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service: The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence: Data is the most valued commodity of the modern world. For P&P it's all about the application....